C-peptide and Type 1 Diabetic Neuropathy
Author Information
Author(s): Anders A. F. Sima, Weixian Zhang, George Grunberger
Primary Institution: Wayne State University
Hypothesis
C-peptide replacement can prevent and improve diabetic peripheral neuropathy (DPN) in type 1 diabetes.
Conclusion
C-peptide replacement shows potential benefits in preventing and improving diabetic neuropathy in type 1 diabetes patients.
Supporting Evidence
- C-peptide improves nerve conduction abnormalities in diabetic models.
- C-peptide prevents apoptosis of nerve cells in type 1 diabetes.
- Clinical trials indicate C-peptide has beneficial effects on nerve function.
- Replacement of C-peptide can ameliorate diabetic neuropathy symptoms.
Takeaway
C-peptide is a part of insulin that helps nerves in people with type 1 diabetes. Giving it back can help their nerves feel better.
Methodology
The study reviews preclinical and clinical findings on the effects of C-peptide on nerve function and regeneration in type 1 diabetes.
Potential Biases
Potential bias due to reliance on preclinical data and small sample sizes in clinical trials.
Limitations
The study primarily relies on animal models and limited clinical trials.
Participant Demographics
The study discusses findings primarily in type 1 diabetic patients and animal models.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website